· Type 1 Diabetes TrialNet: Clinical Centers (U01): RFA-DK-08-011
· Key RFA Dates:
Letter of Intent Receipt Date: February 10, 2009
Application Submission/Receipt Date: March 10, 2009
· Frequently Asked Questions* (Initial Posting: January 7, 2009)
Question 1: Should applicants propose a study using the data and/or samples being collected as part of the TrialNet Natural Study and/or an ongoing or approved TrialNet intervention protocol AND an intervention study in individuals at-risk for T1D or newly-diagnosed with T1D?
Answer: Applicants should propose only one study. This study can use the data and/or samples being collected as part of the TrialNet Natural Study and/or an ongoing or approved TrialNet intervention protocol OR can involve an intervention in individuals at-risk for T1D or newly-diagnosed with T1D.
Question 2: Should study proposals include a study budget?
Answer: The study proposal should not include a study budget. Because TrialNet studies are conducted at numerous sites, estimation of a study budget by an individual center is not feasible. However, applicants should consider feasibility, including budgetary feasibility, in proposing a study. The budget in the application should be developed based on infrastructure support needed for expected participation in multiple TrialNet studies as described in the amended RFA.
Question 3: Can the proposed infrastructure for a site include more than one Co-Investigator?
Answer: The proposed infrastructure may include more than one Co-Investigator as long as the combined effort from the PI and Co-Investigators is commensurate with the levels of effort indicated in the RFA.
Question 4: Can applicants submit more than one application, provided that they are scientifically distinct?
Answer: Individual applicants should not submit more than one application, and institutions should not submit more than one application.
*Please note that this webpage will be updated as additional questions arise.
